A health status questionnaire using 30 items from the medical outcomes study: Preliminary validation in persons with early HIV infection

Medical Care

Volumn 29, Issue 8, 1991, Pages 786-798

  Wu, Albert W ^a   Rubin, Haya R ^a   Mathews, William C ^b   Ware, John E ^c   Brysk, Lucyt ^d   Hardy, William D ^e   Bozzette, Samuel A ^b   Spector, Stephen A ^b   Richman, Douglas D ^b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Acquired immune deficiency virus (AIDS); Clinical trials; Health status; Human immunodeficiency virus (HIV); Quality of life; Questionnaire; Reliability; Validity

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; COMPARATIVE STUDY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; QUALITY OF LIFE; QUESTIONNAIRE; STANDARD;

ADULT; AIDS-RELATED COMPLEX; COMPARATIVE STUDY; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HIV INFECTIONS; HUMAN; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0026210705     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/00005650-199108000-00011     Document Type: Article

References (23)

1. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:185.
2. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:192.
3. Kaplan RM, Anderson JP. The quality of well-being scale: rationale for a single quality of life index. In: Walker CS, ed. Quality of life: assessment and application. London: MTP Press, 1988:51.
4. Brook RH, Ware JE Jr, Davies-Avery A, et al: Overview of the adult health status measures fielded in Rand’s health insurance study. Med Care 1979; 17(Suppl):l.
5. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787.
6. Read JL, Quinn RJ, Hoefer MA. Measuring overall health: an evaluation of three important approaches. J Chron Dis 1987;40:7S.
7. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26:724-735.
8. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. Journal of Acquired Immune Deficiency Syndromes 1990;3:683.
9. Karnofsky DA, Abelman WH, Craver LF, Burcheneal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634.
10. Spitzer WO. State of science 1986: quality of life and functional status as target variables for research. J Chron Dis 1987;40:465.
11. Hutchinson TA, Boyd NF, Feinstein AR, et al. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chron Dis 1979;32:661.
12. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941.
13. Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection: a doubleblind, placebo-controlled trial. Ann Intern Med 1990:112:727.
14. Tarlov AR, Ware JE Jr, Greenfield S, et al. The Medical Outcomes Study: An application of methods for monitoring the results of medical care. JAMA 1989:262:925.
15. Stewart AL, Sherbourne C, Hays RD, et al. Summary and discussion of Medical Outcomes Study measures of functioning and well-being. In: Stewart AL, Ware JE Jr, eds. Measuring function and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press, March 1992.
16. Nelson EC, Landgraf JM, Hays RD, Wasson JH, Kirk JW. The functional status of patients: how can it be measured in physicians’ offices: Med Care 1990; 28:1111.
17. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297.
18. Nunnally JC. Psychometric theory, 2nd ed. New York: McGraw-Hill, 1978.
19. Helmstater GC. Principles of psychological measurement. New York: Appleton-Century-Crofts, 1964.
20. Stewart AL, Ware JE, eds. Measuring function and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press, March 1992.
21. Ware JE. Conceptualizing disease impact and treatment outcomes. Cancer 1984;53(Suppl):2316.
22. Idler EL, Angel RJ. Self-rated health and mortality in the NHANES-I epidemiologic follow-up study. Am J Public Health 1990;80:446.
23. Bindman A, Keane D, Lurie N. Measuring health changes among severely ill patients: the floor phenomenon. Med Care 1990;28:1142.